Larvol Delta - Akava-Therapeutics-Inc-congratulates-SAB-Chair-Dr-Hande-Ozdinler-Founder-Dr-Richard-B-Silverman-and-Dr-William-Klein-on-their-recent-grant-of-73-million-from-the-National-Institute-on-Aging-to-investigate-AKV9-in-neurodegenerative-diseases

AKV9 - Akava Therap

https://www.businesswire.com/news/home/20241216649721/en/Akava-Therapeutics-Inc.-congratulates-SAB-Chair-Dr.-Hande-Ozdinler-Founder-Dr.-Richard-B.-Silverman-and-Dr.-William-Klein-on-their-recent-grant-of-7.3-million-from-the-National-Institute-on-Aging-to-investigate-AKV9-in-neurodegenerative-diseases

Dec 17, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next